Advertisement
Screener

Fortress Biotech, Inc. (FBIO) Shareholder Equity

Fortress Biotech, Inc. (FBIO) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD $3.00K; Common Stock, Value, IssuedUSD $33.00K; Additional Paid in CapitalUSD $788.25M; Retained Earnings (Accumulated Deficit)USD $-624.15M.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD $3.00K; Common Stock, Value, IssuedUSD $33.00K; Additional Paid in CapitalUSD $785.85M; Retained Earnings (Accumulated Deficit)USD $-623.68M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD $3.00K; Common Stock, Value, IssuedUSD $31.00K; Additional Paid in CapitalUSD $783.89M; Retained Earnings (Accumulated Deficit)USD $-734.05M.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD $3.00K; Common Stock, Value, IssuedUSD $31.00K; Additional Paid in CapitalUSD $785.94M; Retained Earnings (Accumulated Deficit)USD $-730.12M.

Fortress Biotech, Inc. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
USD
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
USD
Noncontrolling Interest, Increase from Sale of Parent Equity Interest
USD
Noncontrolling Interest, Decrease from Deconsolidation
USD
Treasury Stock, Preferred, Value
USD
Treasury Stock, Preferred, Shares
shares
Treasury Stock, Value, Acquired, Cost Method
USD
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
Adjustments to Additional Paid in Capital, Other
USD
Noncontrolling Interest, Increase from Subsidiary Equity Issuance
USD
Noncontrolling Interest, Increase from Business Combination
USD
Treasury Stock Acquired, Average Cost Per Share
USD/shares
Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
USD
2026-06-30$3.00K$33.00K$788.25M$-624.15M$164.14M$206.09M3 month · $2.88M
6 month · $4.63M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2026-03-31$3.00K$33.00K$785.85M$-623.68M$162.21M$202.37M3 month · $1.76M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-12-31$3.00K$31.00K$783.89M$-734.05M$49.87M$62.18M12 month · $28.74M(m)(m)12 month · $9.93M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30$3.00K$31.00K$785.94M$-730.12M$55.86M$65.19M3 month · $3.20M
9 month · $26.28M
(m)(m)9 month · $9.93M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-06-30$3.00K$30.00K$779.86M$-735.97M$43.92M$37.38M3 month · $16.79M
6 month · $23.08M
(m)(m)3 month · $9.93M
6 month · $9.93M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31$3.00K$30.00K$773.67M$-751.45M$22.25M$32.49M3 month · $6.29M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-12-31$3.00K$28.00K$763.57M$-740.87M$22.74M$-1.64M12 month · $32.62M12 month · $4.02M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30$3.00K$28.00K$755.23M$-734.10M$21.16M$-12.74M3 month · $6.57M
9 month · $16.43M
9 month · $4.02M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30$3.00K$23.00K$739.09M$-721.24M$17.88M$-14.60M3 month · $5.00M
6 month · $9.86M
3 month · $2.01M
6 month · $4.02M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31$3.00K$19.00K$733.29M$-710.29M$23.02M$-3.94M3 month · $4.86M3 month · $2.01M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$3.00K$15.00K$717.40M$-694.87M$22.54M$1.59M12 month · $17.03M12 month · $8.03M12 month · $6.69M12 month · $6.69M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30$3.00K$9.00K$702.25M$-685.59M$16.67M$-13.24M3 month · $4.38M
9 month · $13.32M
3 month · $2.01M
9 month · $6.02M
3 month · $802.00K
9 month · $6.69M
3 month · $802.00K
9 month · $6.69M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30$3.00K$132.00K$698.90M$-680.55M$18.51M$-15.94M3 month · $4.22M
6 month · $8.95M
3 month · $2.01M
6 month · $4.02M
(m)3 month · $5.89M
6 month · $5.89M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31$3.00K$130.00K$693.43M$-655.77M$37.80M$19.81M3 month · $4.73M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31$3.00K$7.00K$675.94M$-634.23M$41.72M$50.02M12 month · $22.99M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30$3.00K$108.00K$668.65M$-607.09M$61.67M$101.35M3 month · $6.84M
9 month · $17.48M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30$3.00K$108.00K$661.69M$-584.58M$77.22M$147.70M3 month · $5.08M
6 month · $10.64M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31$3.00K$106.00K$660.97M$-563.22M$97.86M$193.58M3 month · $5.56M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$3.00K$101.00K$656.03M$-547.46M$108.67M$225.88M12 month · $19.49M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30$3.00K$99.00K$608.09M$-515.90M$92.66M$212.47M3 month · $4.33M
9 month · $12.45M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$3.00K$97.00K$603.03M$-495.12M$108.28M$248.30M3 month · $4.35M
6 month · $8.12M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31$3.00K$97.00K$597.38M$-491.58M$105.90M$244.22M3 month · $3.77M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$3.00K$95.00K$583.00M$-482.76M$100.34M$197.00M12 month · $13.45M(m)(m)(m)(m)(m)12 month · $72.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30$3.00K$94.00K$574.46M$-477.46M$97.11M$176.15M3 month · $3.17M
9 month · $10.32M
(m)(m)(m)(m)5.00K9 month · $72.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30$3.00K$86.00K$521.49M$-461.92M$60.48M$116.86M3 month · $3.75M
6 month · $7.15M
(m)(m)(m)(m)5.00K6 month · $72.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31$2.00K$79.00K$485.16M$-448.60M$37.23M$75.28M3 month · $3.40M(m)(m)(m)$70.00K5.00K3 month · $72.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$1.00K$74.00K$461.87M$-436.23M$26.21M$72.53M12 month · $13.19M(m)(m)12 month · $4.85M(m)(m)(m)(m)(m)(m)(m)(m)12 month · $4.85M(m)(m)(m)
2019-09-30$1.00K$70.00K$445.97M$-420.74M$25.80M$75.00M3 month · $3.74M
9 month · $10.42M
(m)(m)9 month · $4.85M(m)(m)(m)(m)(m)(m)(m)(m)9 month · $4.85M(m)(m)(m)
2019-06-30$1.00K$68.00K$439.30M$-407.98M$31.87M$89.82M3 month · $3.37M
6 month · $6.68M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)6 month · $4.85M(m)(m)(m)
2019-03-31$1.00K$63.00K$414.87M$-394.88M$20.82M$50.71M3 month · $3.31M(m)(m)3 month · $4.85M(m)(m)(m)(m)(m)(m)(m)(m)3 month · $4.85M(m)(m)(m)
2018-12-31$1.00K$58.00K$397.41M$-396.27M$1.85M$19.74M12 month · $15.01M(m)(m)(m)(m)(m)(m)(m)12 month · $13.90M(m)(m)(m)(m)(m)(m)(m)
2018-09-30$1.00K$56.00K$408.62M$-371.39M$37.77M$84.64M3 month · $4.10M
9 month · $12.04M
(m)(m)(m)(m)(m)(m)(m)(m)(m)9 month · $13.62M(m)(m)(m)(m)9 month · $-82.00K
2018-06-30$1.00K$54.00K$397.86M$-354.76M$43.93M$96.27M3 month · $3.15M
6 month · $7.95M
(m)(m)(m)(m)(m)(m)(m)(m)(m)6 month · $13.62M(m)(m)(m)(m)6 month · $-82.00K
2018-03-31$1.00K$52.00K$374.25M$-333.14M$41.65M$107.55M3 month · $4.79M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31$1.00K$51.00K$364.15M$-312.13M$52.57M$120.50M12 month · $13.40M(m)(m)(m)(m)(m)(m)(m)12 month · $11.30M12 month · $14.01M12 month · $750.00K12 month · $314.00K12 month · $0.00(m)(m)(m)
2017-09-30(m)$51.00K$338.25M$-301.71M$36.94M$121.27M9 month · $12.05M(m)(m)(m)(m)(m)(m)(m)(m)(m)9 month · $750.00K9 month · $314.00K(m)(m)(m)(m)
2017-06-30(m)$50.00K$346.63M$-274.60M$72.27M$150.62M6 month · $7.74M(m)(m)(m)(m)(m)(m)(m)(m)(m)6 month · $750.00K6 month · $314.00K(m)(m)(m)(m)
2017-06-26(m)$800.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-03-31(m)$50.00K$304.93M$-257.23M$47.75M$126.32M3 month · $2.93M(m)(m)(m)(m)(m)(m)(m)(m)(m)3 month · $206.00K(m)(m)(m)(m)(m)
2016-12-31$0.00$49.00K$283.70M$-245.25M$38.49M$82.97M12 month · $12.13M(m)(m)(m)(m)(m)(m)(m)12 month · $9.90M12 month · $12.13M12 month · $793.00K12 month · $2.01M12 month · $0.0012 month · $17.64M(m)(m)
2016-10-31(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)1 month · 0.18(m)
2016-09-30(m)$49.00K$264.40M$-227.82M$36.63M$74.84M9 month · $8.79M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)9 month · $1.88M9 month · $0.009 month · $17.72M(m)(m)
2016-06-30(m)$49.00K$250.13M$-214.84M$35.34M$58.21M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-03-31(m)$49.00K$246.88M$-202.36M$44.56M$70.91M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-12-31(m)$47.00K$246.96M$-190.16M$56.85M$84.27M12 month · $14.29M(m)(m)(m)(m)(m)(m)(m)12 month · $6.90M12 month · $14.29M12 month · $613.00K(m)12 month · $0.00(m)(m)(m)
2015-10-31(m)(m)$50.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30(m)$47.00K$231.68M$-178.12M$53.61M$54.92M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-06-30(m)$47.00K$215.79M$-159.96M$55.88M$55.21M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)6 month · $49.00K(m)(m)(m)
2015-03-31(m)$47.00K$213.89M$-153.78M$60.19M$60.15M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)3 month · $-513.00K(m)(m)(m)
2014-12-31(m)$46.00K$212.21M$-141.73M$70.52M$70.52M12 month · $5.55M(m)(m)(m)(m)(m)(m)(m)12 month · $4.00M(m)(m)(m)(m)(m)(m)(m)
2014-09-30$0.00$44.00K$207.23M$-138.01M$69.26M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-06-30$0.00$44.00K$205.75M$-133.42M$72.37M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31(m)$44.00K$204.16M$-128.71M$75.49M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-12-31$0.00$40.00K$202.58M$-121.34M$81.28M$81.28M12 month · $5.90M(m)(m)(m)(m)(m)(m)12 month · $1.90M12 month · $66.00K
90 month · $2.20M
(m)(m)(m)(m)(m)(m)(m)
2013-09-30(m)$35.00K$199.02M$-111.54M$87.51M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)9 month · $4.07M(m)(m)(m)(m)(m)(m)
2013-06-30(m)$30.00K$152.24M$-103.71M$48.56M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31(m)$26.00K$119.74M$-93.04M$26.73M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31(m)$24.00K$106.19M$-84.18M$22.03M$22.03M12 month · $3.96M(m)(m)(m)(m)(m)(m)12 month · $2.31M(m)(m)(m)(m)(m)(m)(m)(m)
2012-10-05(m)$30.00M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30(m)$24.00K$104.62M$-75.52M$29.13M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-06-30(m)$24.00K$103.38M$-69.58M$33.82M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-03-31(m)$19.00K$76.56M$-63.13M$13.45M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31(m)$19.00K$75.69M$-56.57M$19.13M(m)12 month · $1.47M(m)(m)(m)(m)(m)(m)(m)(m)(m)12 month · $2.69M12 month · $30.00K(m)(m)(m)(m)
2011-09-30(m)$7.00K$5.21M$-49.85M$-44.64M(m)9 month · $566.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)9 month · $30.00K(m)(m)(m)(m)
2010-12-31(m)$5.00K$4.31M$-20.21M$-15.90M(m)12 month · $2.33M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)12 month · $40.00K(m)(m)(m)(m)
2009-12-31(m)(m)(m)(m)$-15.90M(m)12 month · $39.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)12 month · $40.00K(m)(m)(m)(m)
2008-12-31(m)(m)(m)(m)$5.00K(m)12 month · $25.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)12 month · $20.00K(m)(m)(m)(m)
2007-12-31(m)(m)(m)(m)$-2.75M(m)12 month · $13.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2006-12-31(m)(m)(m)(m)$-123.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2006-06-27(m)(m)(m)(m)$0.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
PepGen Inc. (PEPG)United States$0.186B-1.73
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39